FDA Approves GARDASIL(R) For Use In Boys And Young Men

Links shared publicly online about this topic.

  • 1,663
    total visits

FDA Approves GARDASIL(R) For Use In Boys And Young Men

medicalnewstoday.com

Merck & Co., Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] for

View full resource at medicalnewstoday.com

Tags: Wart, STD, HPV, Drug, Men's Health, FDA, Vaccine, Merck & Co.

  • Share

Most Recently Shared on October 20, 2009 at 10:40 am By:

mnt_pediatrics MNT Pediatrics News

FDA Approves GARDASIL(R) For Use In Boys And Young Men: Merck & Co., Inc. announced today that the U.S. Food an.. http://bit.ly/RvN6d

3 years ago...

FDA Approves Gardasil for Use in Boys and Young Men

drugs.com — “Gardasil (Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) is used in boys and men 9 through 26 years of age for the prevention of genital warts caused by human papillomavirus (HPV) types 6 and 11. Includes Gardasil side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on October 16, 2009 at 11:21 pm By:

drugscom Drugs.com Health Site

FDA Approves Gardasil for Use in Boys and Young Men - http://bit.ly/22tTYH

3 years ago...

StreetInsider.com - Merck (MRK) Receives FDA Approval for GARDASIL(R) in Boys and Young Men

streetinsider.com — “StreetInsider.com - Merck (MRK) Receives FDA Approval for GARDASIL(R) in Boys and Young MenView full resource at streetinsider.com

  • View Related
  • Share

Most Recently Shared on October 16, 2009 at 5:37 pm By:

RitaRubin RitaRubin Health Communicator

Merck still leg up on GSK: FDA OKs Gardasil 4 males, Cervarix only 4 girls & young women. Will ACIP push Gardasil 4 males? http://tr.im/C1J1

3 years ago...

FDA panel backs use of Gardasil in boys, young men - Related Stories - AAP SmartBrief

smartbrief.com — “FDA advisers endorsed the approval of Merck & Co.'s vaccine Gardasil to prevent human papillomavirus infection in males ages 9 to 26. The panel reached the decision after reviewing data from clinical trials involving more than 5,400 boys and men from six continents and 23 countries. <a href='/servleView full resource at smartbrief.com

  • View Related
  • Share

Most Recently Shared on September 12, 2009 at 1:39 am By:

Advertisement